Do ASD and ADHD Have Distinct Executive Function Deficits? A Systematic Review and Meta-Analysis of Direct Comparison Studies.


Journal

Journal of attention disorders
ISSN: 1557-1246
Titre abrégé: J Atten Disord
Pays: United States
ID NLM: 9615686

Informations de publication

Date de publication:
12 2023
Historique:
medline: 10 11 2023
pubmed: 11 8 2023
entrez: 11 8 2023
Statut: ppublish

Résumé

To evaluate if children and adolescents with a diagnosis of ASD or ADHD have distinct executive function (EF) profiles. Peer-reviewed articles comparing ASD, ADHD, and typically developing individuals under 19 years of age were identified. The domains evaluated were: working memory, response inhibition, planning, cognitive flexibility, attention, processing speed, and visuospatial abilities. Fifty-eight articles met inclusion criteria. Analyses were performed on 45 performance metrics from 24 individual tasks. No differences in EF were found between individuals diagnosed with ASD and ADHD. Individuals diagnosed with ASD and ADHD exhibited worse performance in attention, flexibility, visuospatial abilities, working memory, processing speed, and response inhibition than typically developing individuals. Groups did not differ in planning abilities. Children and adolescents with ASD and ADHD have similar EF profiles. Further research is needed to determine if comorbidity accounts for the commonality in executive dysfunction between each disorder.

Identifiants

pubmed: 37565325
doi: 10.1177/10870547231190494
pmc: PMC10637091
doi:

Types de publication

Meta-Analysis Systematic Review Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1571-1582

Subventions

Organisme : CIHR
ID : MOP-93696
Pays : Canada
Organisme : CIHR
ID : MOP-106573
Pays : Canada

Déclaration de conflit d'intérêts

Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Références

Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
Stat Med. 2002 Jun 15;21(11):1539-58
pubmed: 12111919
J Clin Child Adolesc Psychol. 2019 May-Jun;48(3):455-468
pubmed: 29847154
J Abnorm Child Psychol. 2007 Apr;35(2):229-38
pubmed: 17351752
Elife. 2019 Apr 29;8:
pubmed: 31033438
J Autism Dev Disord. 1999 Apr;29(2):171-7
pubmed: 10382139
Occup Environ Med. 2021 Sep;78(9):621-622
pubmed: 34158356
J Int Neuropsychol Soc. 2010 May;16(3):495-505
pubmed: 20188014
Am J Psychiatry. 2010 Jul;167(7):748-51
pubmed: 20595427
BMJ. 2009 Jul 21;339:b2700
pubmed: 19622552
Neurology. 2013 Mar 12;80(11 Suppl 3):S1
pubmed: 23479536
Transl Psychiatry. 2017 Aug 22;7(8):e1218
pubmed: 28892073
Res Child Adolesc Psychopathol. 2023 Jan;51(1):17-31
pubmed: 36006496
Clin Psychol Rev. 2022 Nov;97:102194
pubmed: 35964337
J Child Psychol Psychiatry. 1991 Nov;32(7):1063-80
pubmed: 1787137
Annu Rev Psychol. 2013;64:135-68
pubmed: 23020641
J Epidemiol Community Health. 1998 Jun;52(6):377-84
pubmed: 9764259
Arq Neuropsiquiatr. 2018 Feb;76(2):89-92
pubmed: 29489962
Dev Sci. 2013 Mar;16(2):269-286
pubmed: 23432836
Mol Psychiatry. 2013 Feb;18(2):236-44
pubmed: 22290121
Hippokratia. 2010 Dec;14(Suppl 1):29-37
pubmed: 21487488
J Can Acad Child Adolesc Psychiatry. 2012 Aug;21(3):223-9
pubmed: 22876270
Dev Sci. 2005 Mar;8(2):132-40
pubmed: 15720371
J Exp Psychol Gen. 2001 Dec;130(4):621-640
pubmed: 11757872
J Abnorm Child Psychol. 2018 Nov;46(8):1705-1716
pubmed: 29450820
Psychol Methods. 2006 Jun;11(2):193-206
pubmed: 16784338
Neurosci Biobehav Rev. 2016 Dec;71:529-541
pubmed: 27629802
MMWR Surveill Summ. 2020 Mar 27;69(4):1-12
pubmed: 32214087
Dev Psychol. 2014 Apr;50(4):1037-48
pubmed: 24188038
Front Psychiatry. 2021 Dec 20;12:654120
pubmed: 34987421
Child Adolesc Psychiatr Clin N Am. 2000 Jul;9(3):711-26
pubmed: 10944664
Psychol Bull. 1997 Jan;121(1):65-94
pubmed: 9000892
Front Psychol. 2018 Mar 14;9:329
pubmed: 29593624
Child Neuropsychol. 2020 Feb;26(2):257-273
pubmed: 31331259
Curr Psychiatry Rep. 2019 Mar 22;21(5):34
pubmed: 30903299
Environ Res. 2018 Oct;166:481-486
pubmed: 29957501
Front Psychiatry. 2022 Feb 28;13:837424
pubmed: 35295773
Neuropsychiatr Dis Treat. 2016 May 12;12:1191-202
pubmed: 27274255
J Autism Dev Disord. 2010 Aug;40(8):1017-27
pubmed: 20140638
Int J Epidemiol. 2014 Apr;43(2):434-42
pubmed: 24464188

Auteurs

Parker Townes (P)

University of Calgary, AB, Canada.

Chunlin Liu (C)

University of Toronto, ON, Canada.

Prabdeep Panesar (P)

University of Toronto, ON, Canada.

Daniel Devoe (D)

Mount Royal University, Calgary, AB, Canada.

Soo Youn Lee (SY)

University of Toronto, ON, Canada.

Gracie Taylor (G)

Mount Royal University, Calgary, AB, Canada.

Paul D Arnold (PD)

University of Calgary, AB, Canada.

Jennifer Crosbie (J)

University of Toronto, ON, Canada.

Russell Schachar (R)

University of Toronto, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH